CLINICAS CRES, a promising entity in the health sector, is at the cutting edge of Regenerative Medicine, Nutrition, Genetics, and Aesthetic Medicine. Founded in 2013, the company has established a significant presence in Spain, advancing health care through state-of-the-art innovations.
As part of the Peaches Biotech group, CLINICAS CRES leverages expertise in groundbreaking cell therapy and stem cell techniques, making significant strides in the development of technologically advanced medical machines. With their commitment encapsulated in the slogan: "Advanced clinics in Regenerative Medicine, Nutrition, Genetics, Aesthetic Medicine and Sports Medicine," the company signifies a robust approach to modern health care solutions.
Currently, CLINICAS CRES does not have recorded outside investment, providing a strategic opportunity for venture capitalists looking to enter the health sector's innovative edge. As they continue to innovate, investment in this company could fuel further expansion and technological advancement in health care.